Cell Therapy Products in Alzheimer DiseaseCell Therapy Products in Alzheimer Disease
- Other Titles
- Cell Therapy Products in Alzheimer Disease
- Authors
- 송현진; 김태희; 이해혁; 김준모; 박유진; 이아름; 김수아; 최혜지
- Issue Date
- 2017
- Publisher
- 대한폐경학회
- Keywords
- Alzheimer’s disease ∙ Cell- and tissue-based therapy ∙ Menopause ∙ Stem cells
- Citation
- 대한폐경학회지, v.23, no.1, pp 1 - 4
- Pages
- 4
- Journal Title
- 대한폐경학회지
- Volume
- 23
- Number
- 1
- Start Page
- 1
- End Page
- 4
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8299
- ISSN
- 2288-6478
2288-6761
- Abstract
- We are rapidly becoming an aging society, with the ongoing increase in challenges of the elderly. The age-related cognitivedecline in accordance with aging society is of major importance in public health. Recent studies have proved the impacts of sexsteroidhormone on the brain; compliant with aging, menopause and decrease in estrogen have an effect on the occurrenceand prevention of Alzheimer’s disease. A new hypothesis states that Alzheimer’s disease is a postmenopausal dementia, andis a negative form of estrogen deficiency. In this review article, we reckoned the cause of postmenopausal Alzheimer’s disease.
We further investigated new cell therapies for postmenopausal Alzheimer’s disease, which are under development in somepharmaceutical companies. One remedy is cell therapy that inhibits the amyloid beta formation, and the other is the umbilical cordblood derived mesenchymal stem cell therapy. (J Menopausal Med 2017;23:1-4)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Urology > 1. Journal Articles
- College of Medicine > Department of Obstetrics and Gynecology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8299)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.